Trying huperzine A put me on the path to being diagnosed with MG
Columnist Shawna Barnes was on the hunt for a clue to her MG symptoms when a late-night search on the internet brought her to huperzine A.| Myasthenia Gravis News
Columnist Shawna Barnes was on the hunt for a clue to her MG symptoms when a late-night search on the internet brought her to huperzine A.| Myasthenia Gravis News
Columnist Shawna Barnes is ready for some emotional separation from myasthenia gravis, so she's delivering it a breakup letter.| Myasthenia Gravis News
Gefurulimab outperformed a placebo in easing gMG symptoms in a clinical trial involving over 250 patients positive for anti-AChR antibodies.| Myasthenia Gravis News
The FDA has approved once-daily zilucoplan as Zilbrysq for adults with generalized MG who are positive for antibodies targeting AChR.| Myasthenia Gravis News
Study data show long-term treatment with Zilbrysq led to sustained reductions in disease severity in generalized myasthenia gravis patients.| Myasthenia Gravis News
Researchers say the case suggests Vyvgart can be an alternative drug for achieving minimal manifestation status during a myasthenic crisis.| Myasthenia Gravis News
Fatigue linked to myasthenia gravis can affect a person’s quality of life, but there are coping strategies that can be used to minimize it.| Myasthenia Gravis News
Marisa Wexler is a senior science writer for Myasthenia Gravis News with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of myasthenia gravis topics.| Myasthenia Gravis News
Remegen enrolled the first U.S. patient in a Phase 3 trial testing the safety and efficacy of telitacicept for generalized myasthenia gravis.| Myasthenia Gravis News
The anti-malaria drug dihydroartemisinin, known as DHA, showed promise for treating myasthenia gravis in a rat model of MG, per a new study.| Myasthenia Gravis News
